Braveheart Bio (BRVE US)

Braveheart Bio, Inc. is a clinical-stage biotechnology company. The Company focuses on developing therapeutics to treat hypertrophic cardiomyopathy (HCM) and related conditions by targeting overactive proteins within the heart. Braveheart Bio serves customers in the United States.